Helsinki - Free Realtime Quote EUR

Biohit Oyj (BIOBV.HE)

Compare

2.9700

-0.0200

(-0.67%)

As of 10:51:03 AM GMT+2. Market Open.

Currency in EUR All numbers in thousands

Download

Breakdown

TTM

12/31/2023

12/31/2022

12/31/2021

12/31/2020

Total Revenue

13,076.0000

10,951.0000

9,361.0000

7,123.0000

Cost of Revenue

4,792.0000

3,840.0000

3,447.0000

3,165.0000

Gross Profit

8,284.0000

7,111.0000

5,914.0000

3,958.0000

Operating Expense

6,639.0000

5,982.0000

7,415.0000

7,133.0000

Operating Income

1,645.0000

1,129.0000

-1,501.0000

-3,175.0000

Net Non Operating Interest Income Expense

277.0000

-286.0000

105.0000

-20.0000

Pretax Income

2,195.0000

868.0000

-1,305.0000

-3,261.0000

Tax Provision

344.0000

267.0000

195.0000

51.0000

Net Income Common Stockholders

1,851.0000

601.0000

-1,500.0000

-3,313.0000

Diluted NI Available to Com Stockholders

1,851.0000

601.0000

-1,500.0000

-3,313.0000

Basic EPS

0.12

0.04

-0.10

-0.22

Diluted EPS

0.12

0.04

-0.10

-0.22

Basic Average Shares

15,097.1530

15,045.5930

Diluted Average Shares

15,127.3610

15,065.4860

15,045.5930

Total Operating Income as Reported

1,825.0000

1,129.0000

-1,480.0000

-3,174.0000

Rent Expense Supplemental

122.0000

139.0000

107.0000

90.0000

Total Expenses

11,431.0000

9,822.0000

10,862.0000

10,298.0000

Net Income from Continuing & Discontinued Operation

1,851.0000

601.0000

-1,500.0000

-3,313.0000

Normalized Income

1,797.8733

576.7661

-1,569.6000

-3,381.0000

Interest Income

500.0000

100.0000

Interest Expense

200.0000

34.0000

9.0000

14.0000

Net Interest Income

277.0000

-286.0000

105.0000

-20.0000

EBIT

1,645.0000

1,129.0000

-1,296.0000

-3,247.0000

EBITDA

2,008.0000

1,609.0000

693.0000

-1,250.0000

Reconciled Cost of Revenue

4,792.0000

3,840.0000

3,447.0000

3,165.0000

Reconciled Depreciation

363.0000

480.0000

1,989.0000

1,997.0000

Net Income from Continuing Operation Net Minority Interest

1,851.0000

601.0000

-1,500.0000

-3,313.0000

Total Unusual Items Excluding Goodwill

63.0000

35.0000

87.0000

85.0000

Total Unusual Items

63.0000

35.0000

87.0000

85.0000

Normalized EBITDA

1,945.0000

1,574.0000

606.0000

-1,335.0000

Tax Rate for Calcs

0.0002

0.0003

0.0002

Tax Effect of Unusual Items

9.8733

10.7661

17.4000

17.0000

12/31/2020 - 1/3/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

FARON.HE Faron Pharmaceuticals Oy

2.0500

-2.61%

HRTIS.HE Herantis Pharma Oyj

1.5500

-1.90%

CDTX Cidara Therapeutics, Inc.

18.10

+1.40%

CYBN Cybin Inc.

9.98

+1.22%

ADMA ADMA Biologics, Inc.

16.10

-1.71%

AKRO Akero Therapeutics, Inc.

55.36

+2.52%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Biohit Oyj (BIOBV.HE)

Upgrade to begin using 40 years of financial statements and get so much more.

Related Tickers